BiotechTube

Micronized DHACM + Saline Injection

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tendonitis;Achilles

Conditions

Tendonitis;Achilles

Trial Timeline

Jan 9, 2018 → Mar 30, 2021

NCT ID
NCT03414255

About Micronized DHACM + Saline Injection

Micronized DHACM + Saline Injection is a phase 3 stage product being developed by MiMedx Group for Tendonitis;Achilles. The current trial status is completed. This product is registered under clinical trial identifier NCT03414255. Target conditions include Tendonitis;Achilles.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03414255Phase 3Completed

Other Products from MiMedx Group

Saline InjectionPhase 3
72
Saline InjectionPhase 2/3
60
Micronized dHACM + SalinePhase 2
47
AmnioFix®Phase 2
47
Micronized DHACM 40 mg + Micronized DHACM 100 mg + SalinePhase 2
47